Continuous subcutaneous insulin infusion in patients with type 1 disease

Meetoo, D, Wong, L and Fatani, T 2017, 'Continuous subcutaneous insulin infusion in patients with type 1 disease' , British Journal of Healthcare Management, 23 (7) , pp. 313-318.

Full text not available from this repository. (Request a copy)


Optimal blood glucose control and the restoration of physiological insulin secretion is an ongoing medical challenge. Continuous subcutaneous insulin infusion (CSII) aims to restore blood glucose levels and reduce the frequency of hypoglycaemic events. Its benefits include a better glycaemic profile compared with management involving multiple daily insulin injections and giving individuals more flexibility in their everyday lives. The advantages of insulin pumps include basal delivery consistency, adjustable basal rates and low insulin depots. However, experience with CSII indicates that candidates should be selected carefully, be well educated in how use the device and be highly motivated to improve their blood glucose control.

Item Type: Article
Schools: Schools > School of Health and Society
Journal or Publication Title: British Journal of Healthcare Management
Publisher: Mark Allen Group
ISSN: 1358-0574
Related URLs:
SWORD Depositor: Publications Router
Depositing User: Publications Router
Date Deposited: 30 Aug 2017 11:36
Last Modified: 27 Aug 2021 20:41

Actions (login required)

Edit record (repository staff only) Edit record (repository staff only)